The document summarizes key points of Republic Act No. 11525, which establishes the COVID-19 Vaccination Program in the Philippines. It authorizes the Department of Health and National Task Force to procure COVID-19 vaccines and related supplies. It allows local governments and private entities to procure vaccines in cooperation with DOH and NTF. It establishes a COVID-19 National Vaccine Indemnity Fund administered by PhilHealth to compensate people who experience serious adverse effects from vaccines. It also exempts COVID-19 vaccination efforts from import duties and taxes.
This document provides frequently asked questions and answers about the UN's COVID-19 vaccination program. It explains that UN personnel will receive vaccines through national programs where possible, and the UN is making alternative arrangements where needed. It describes who is eligible for the UN vaccination program and how vaccines will be prioritized. It also addresses questions about vaccine safety, coverage, requirements, and post-vaccination behavior.
Legal developments for telehealth amid covid 19VSee
The document summarizes recent legal developments around telehealth coverage and policies amid the COVID-19 pandemic. It outlines temporary expansions of telehealth coverage by Medicare, Medicaid, commercial health plans, and self-funded ERISA plans. Regulations have been relaxed regarding practice across state lines, certain HIPAA requirements, and federal anti-fraud rules. Additional funding opportunities are provided by the CARES Act. Many changes are described as temporary, and it remains to be seen which could become permanent to improve healthcare access.
Coronavirus Nursing Homes Preparedness ChecklistTrustRobin
DOH is conducting Covid-19 focus surveys in long term care facilities .
Suggestions:
* Prepare a separate entrance binder for this focus survey
* Use the CE pathway to identify deficient practices
GLOBAL VACCINATION: HOW THE EVOLVING HEALTHCARE INFRASTRUCTURE IS SUPPORTING ...Anayasharma10
COVID-19 (coronavirus) vaccines have started becoming accessible in most countries and are probably a severe product in fighting the pandemic in 2021. Several vaccines are already in the development trails or phase three trials that have reported promising data in the initial phase, with some receiving authorization for use.
The international health regulations (IHR) is an agreement among 194 countries, including all WHO member countries ,to work together for healthy security of the world. Under the IHR, all countries need to report all events of international public health impact
APCRSHR10 Virtual Plenary presentation of Mr Quazi AKM Mohiul Islam (COVID-19...CNS www.citizen-news.org
This is the Plenary Presentation of Mr Quazi AKM Mohiul Islam, which took place as part of Sixth session of 10th Asia Pacific Conference on Reproductive and Sexual Health and Rights (APCRSHR10) Virtual, on 31st August 2020, on the theme of "Innovative financing for sexual and reproductive health and rights (SRHR) in Asia and the Pacific".
SESSION CHAIR
Dr Ashish Bajracharya
Population Council's Deputy Director for global country strategy and regional representative for South and East Asia
PLENARY SPEAKER
Quazi AKM Mohiul Islam
former Director General, Directorate General of Family Planning, Ministry of Health and Family Welfare, Bangladesh
"COVID-19 and SRHR issues in Bangladesh"
A B S T R A C T P R E S E N T A T I O N S
* Loida Almendares
Sexual and Reproductive Health and Rights in the Context of Socioeconomic Development and Equity Sustainable and innovative financing to ensure SRHR access to all, with "Public-Private Partnership Bridge Funding"
* Dr Moazzam Ali
Are family planning vouchers effective in increasing use, improving equity and reaching the underserved? An evaluation of a voucher program in Pakistan
* Prof Angela Dawson
Launch of the Asia Pacific Consortium for Emergency Contraception (APCEC)
* Zahra Fathi Geshnigani
Investing for health, advocating on prioritizing resource mobilization and allocation for treatment of Sexual transmitted infections; sensitizing stakeholders and policy maker for supporting the HCV treatment for vulnerable groups in Iran
For more information on this session go to www.bit.ly/apcrshr10virtual6
#SRHR #sexualhealth #reproductiverights #familyplanning #womenshealth #LGBT #genderequality #SDGs
The document provides an overview of South Korea's health system response to COVID-19. Key measures included transparent communication, social distancing guidelines, extensive testing and contact tracing, increasing hospital capacity, and maintaining access to healthcare. The country's universal health coverage system supported its efficient mobilization of resources to test, treat, and manage COVID-19 cases.
This document provides frequently asked questions and answers about the UN's COVID-19 vaccination program. It explains that UN personnel will receive vaccines through national programs where possible, and the UN is making alternative arrangements where needed. It describes who is eligible for the UN vaccination program and how vaccines will be prioritized. It also addresses questions about vaccine safety, coverage, requirements, and post-vaccination behavior.
Legal developments for telehealth amid covid 19VSee
The document summarizes recent legal developments around telehealth coverage and policies amid the COVID-19 pandemic. It outlines temporary expansions of telehealth coverage by Medicare, Medicaid, commercial health plans, and self-funded ERISA plans. Regulations have been relaxed regarding practice across state lines, certain HIPAA requirements, and federal anti-fraud rules. Additional funding opportunities are provided by the CARES Act. Many changes are described as temporary, and it remains to be seen which could become permanent to improve healthcare access.
Coronavirus Nursing Homes Preparedness ChecklistTrustRobin
DOH is conducting Covid-19 focus surveys in long term care facilities .
Suggestions:
* Prepare a separate entrance binder for this focus survey
* Use the CE pathway to identify deficient practices
GLOBAL VACCINATION: HOW THE EVOLVING HEALTHCARE INFRASTRUCTURE IS SUPPORTING ...Anayasharma10
COVID-19 (coronavirus) vaccines have started becoming accessible in most countries and are probably a severe product in fighting the pandemic in 2021. Several vaccines are already in the development trails or phase three trials that have reported promising data in the initial phase, with some receiving authorization for use.
The international health regulations (IHR) is an agreement among 194 countries, including all WHO member countries ,to work together for healthy security of the world. Under the IHR, all countries need to report all events of international public health impact
APCRSHR10 Virtual Plenary presentation of Mr Quazi AKM Mohiul Islam (COVID-19...CNS www.citizen-news.org
This is the Plenary Presentation of Mr Quazi AKM Mohiul Islam, which took place as part of Sixth session of 10th Asia Pacific Conference on Reproductive and Sexual Health and Rights (APCRSHR10) Virtual, on 31st August 2020, on the theme of "Innovative financing for sexual and reproductive health and rights (SRHR) in Asia and the Pacific".
SESSION CHAIR
Dr Ashish Bajracharya
Population Council's Deputy Director for global country strategy and regional representative for South and East Asia
PLENARY SPEAKER
Quazi AKM Mohiul Islam
former Director General, Directorate General of Family Planning, Ministry of Health and Family Welfare, Bangladesh
"COVID-19 and SRHR issues in Bangladesh"
A B S T R A C T P R E S E N T A T I O N S
* Loida Almendares
Sexual and Reproductive Health and Rights in the Context of Socioeconomic Development and Equity Sustainable and innovative financing to ensure SRHR access to all, with "Public-Private Partnership Bridge Funding"
* Dr Moazzam Ali
Are family planning vouchers effective in increasing use, improving equity and reaching the underserved? An evaluation of a voucher program in Pakistan
* Prof Angela Dawson
Launch of the Asia Pacific Consortium for Emergency Contraception (APCEC)
* Zahra Fathi Geshnigani
Investing for health, advocating on prioritizing resource mobilization and allocation for treatment of Sexual transmitted infections; sensitizing stakeholders and policy maker for supporting the HCV treatment for vulnerable groups in Iran
For more information on this session go to www.bit.ly/apcrshr10virtual6
#SRHR #sexualhealth #reproductiverights #familyplanning #womenshealth #LGBT #genderequality #SDGs
The document provides an overview of South Korea's health system response to COVID-19. Key measures included transparent communication, social distancing guidelines, extensive testing and contact tracing, increasing hospital capacity, and maintaining access to healthcare. The country's universal health coverage system supported its efficient mobilization of resources to test, treat, and manage COVID-19 cases.
In a meeting chaired by PM Modi, it was decided to open up vaccination to all adults over 18 from May 1st. The government announced a liberalized and accelerated Phase 3 vaccination strategy making pricing, procurement, eligibility and administration more flexible. All individuals over 18 will be eligible for vaccination and vaccine manufacturers can now supply 50% of their monthly production to state governments and the open market. The government vaccination program will continue providing free vaccination to priority groups.
The SAFE TO WORK Act (S. 4317) was first introduced as standalone legislation on July 20. The text of this proposed COVID-19 liability shield is included within the “skinny” coronavirus relief bill that recently failed a key vote in the Senate.
As detailed in the attached, the SAFE TO WORK Act would afford U.S. businesses, nonprofits and local governments protections against liability for COVID-19 infections markedly stronger than those available under the immunity statutes enacted by the States.
Under the proposed federal law, a plaintiff infected with COVID-19 would be required to prove through “clear and convincing” evidence:
• The defendant failed to make reasonable efforts to comply with applicable government standards or guidance to mitigate the transmission of COVID-19;
• The defendant acted with gross negligence or willful misconduct; and
• That gross negligence or willful misconduct caused the plaintiff to contract COVID-19.
1. The document discusses the preparedness and awareness of the Local Government Unit (LGU) of Cagayan de Oro City amidst the COVID-19 pandemic.
2. It finds that the majority of respondents considered the LGU's preparedness and awareness in terms of knowledge, preparedness, information update, and preventive measures to be highly effective.
3. The study recommends extending community quarantines, increasing testing and resources for frontline healthcare workers, continuing economic relief for those impacted, and increasing investment in research institutions.
The document outlines South Africa's strategy for rolling out Covid-19 vaccines. It establishes a Ministerial Advisory Committee on vaccines to provide advice on vaccine options, purchasing, priority groups, and rollout strategy. It proposes a phased rollout approach prioritizing healthcare workers, essential workers, elderly, and those with comorbidities. The strategy considers vaccine selection criteria like availability, efficacy, storage requirements, and cost. It also addresses regulatory approvals, procurement, distribution, data collection, and negotiations with vaccine manufacturers.
“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”PYA, P.C.
PYA Principal Martie Ross spoke at the virtual North Carolina Healthcare Association Critical Access Hospital Statewide Meeting. The two-day event, “Quality Focus is a Finance Focus,” provided critical access hospital leaders with the opportunity to network and review data-informed strategies as well as updates to the Medicare Flexibility Program Project. It also provided guidance on federal compliance and tracking of Provider Relief Funds.
In “CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting,” Martie gave an overview of the history of distribution of those funds as well as regulations and guidelines including:
Statutory Language
Reporting Requirements
Use of Funds Calculation
Expenses
Risk Management
Martie presented Thursday, March 4, 2021.
If you would like guidance related to Provider Relief Fund regulations, or for assistance with any matter related to strategy and integration, compliance, or valuation, contact one of our PYA executives at (800) 270-9629.
The Fight Against COVID-19: A National Patient RegistryHealth Catalyst
Comprehensive COVID-19 understanding is a critical asset for adapting to pandemic needs, directing resources, developing vaccines, and planning for surges in a timely, informed manner. Because common barriers have impeded the progress of comprehensive data repositories, researchers have relied on surveillance data from population-level viral testing, which has proven insufficient. To significantly advance COVID-19 understanding, the medical community needs a digital patient registry that captures national-level data on how the virus impacts individuals differently according to comorbidities, lifestyle factors, and more. These essential insights lie in real-world evidence, which a registry can only deliver when it applies value sets to leverage clinical and claims data from health systems across the United States.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of December 2021. However, concerns are raised about the capacity to produce enough doses to vaccinate those aged 18-44 by that time.
2) The previous single procurement model, where the central government procured vaccines for all, has been replaced with a liberalized policy where states must procure vaccines for those 18-44 from private manufacturers.
3) Differential pricing has been introduced, with states paying more per dose than the central government's rate. This is argued to disproportionately impact certain states and individuals.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
Leaving no one behind: Progress on Life Course Immunisation Roundtable – alon...ILC- UK
Leaving no one behind: Progress on Life Course Immunisation Roundtable – alongside the World Health Assembly
Date: Tuesday 23 May 2023
Time: 13.00 – 14.30 (CET), followed by refreshments
Location: Geneva Press Club, Geneva, Switzerland
COVID Vaccine Lawsuit How to Battle your InjuryEdwina Johnson
It is crucial to discuss COVID vaccine injuries and COVID vaccine lawsuits. Medical innovations, particularly vaccine engineering, have a long road ahead of them, but it is one that is paved with a resolve to see to it that people get the treatment and pay they are legally entitled to.
The document summarizes Africa's joint continental strategy for responding to the COVID-19 pandemic, as endorsed by African Union health ministers in February 2020. It outlines the objectives of limiting virus transmission, severe illness, and social/economic disruption. It then describes Africa CDC's coordination of the response, including convening regular meetings, providing guidance and training to member states, deploying rapid response teams, and distributing medical supplies. It also discusses the Africa Medical Supplies Platform established to ensure member states can access critical supplies, and the AU COVID-19 Response Fund set up to address the pandemic's socioeconomic and humanitarian impacts.
When it comes to telehealth, in 2020 so many things changed and we continue to see changes into 2021. While some changes are designated as temporary; others such as the expansion of certain telehealth services may be here to stay. During this presentation, we’ll discuss the changes in telemedicine as a result of COVID-19; what was included in temporary Social Security Act section 1135 waivers and what telemedicine services are expected to remain after the public health emergency is officially over.
We’ll then move on to a more recent challenge with COVID-19 vaccines. We’ll review the vaccines approved for Emergency Use Authorization, and discuss billing guidelines from CMS.
Whether your organization is PPS, CAH, FQHC, RHC or IHS, during this information-packed webinar, we will be addressing vaccine billing guidance for all facility types.
Crossing the Rubicon: Post Covid-19 PolicyKan Yuenyong
The document discusses development policy strategies for post-COVID resilience and recovery. It notes that COVID has exposed weaknesses in economies and increased inequalities. Key issues for sustainable recovery include better health/well-being, cleaner air, public participation, equitable resilience, and pursuing a green/digital/inclusive transformation. Fiscal policy priorities are continuing support, implementing measures efficiently, and pursuing medium-term strategies. Global cooperation is needed on public health and stimulating growth.
This guidance from the WHO provides recommendations for countries to maintain essential health services during the COVID-19 outbreak. It suggests establishing simplified governance mechanisms to coordinate the response while continuing essential services. Countries should identify which services are most critical to prioritize, and may need to optimize service delivery locations and platforms. It also emphasizes the importance of effective patient screening, triage, and referral processes. Finally, the document recommends rapidly redistributing health workers through task sharing and reassignment to help address shortages caused by the increased demands of the outbreak.
Enforcement Discretion for Telehealth Remote Communications during COVID-19VSee
The Office for Civil Rights (OCR) at the Department of Health and Human Services announced it will not impose penalties on healthcare providers for HIPAA non-compliance related to good faith provision of telehealth during the COVID-19 pandemic. OCR will allow popular video communication technologies like FaceTime, Facebook Messenger video, and Google Hangouts for telehealth without penalties. However, public-facing apps like Facebook Live should not be used. OCR encourages use of encrypted, HIPAA-compliant options and notifies that it has not reviewed specific vendors' agreements.
सुप्रीम कोर्ट ने यह भी माना था कि मजिस्ट्रेट का यह कर्तव्य है कि वह सुनिश्चित करे कि अधिकारी पीएमएलए के तहत निर्धारित प्रक्रिया के साथ-साथ संवैधानिक सुरक्षा उपायों का भी उचित रूप से पालन करें।
In a meeting chaired by PM Modi, it was decided to open up vaccination to all adults over 18 from May 1st. The government announced a liberalized and accelerated Phase 3 vaccination strategy making pricing, procurement, eligibility and administration more flexible. All individuals over 18 will be eligible for vaccination and vaccine manufacturers can now supply 50% of their monthly production to state governments and the open market. The government vaccination program will continue providing free vaccination to priority groups.
The SAFE TO WORK Act (S. 4317) was first introduced as standalone legislation on July 20. The text of this proposed COVID-19 liability shield is included within the “skinny” coronavirus relief bill that recently failed a key vote in the Senate.
As detailed in the attached, the SAFE TO WORK Act would afford U.S. businesses, nonprofits and local governments protections against liability for COVID-19 infections markedly stronger than those available under the immunity statutes enacted by the States.
Under the proposed federal law, a plaintiff infected with COVID-19 would be required to prove through “clear and convincing” evidence:
• The defendant failed to make reasonable efforts to comply with applicable government standards or guidance to mitigate the transmission of COVID-19;
• The defendant acted with gross negligence or willful misconduct; and
• That gross negligence or willful misconduct caused the plaintiff to contract COVID-19.
1. The document discusses the preparedness and awareness of the Local Government Unit (LGU) of Cagayan de Oro City amidst the COVID-19 pandemic.
2. It finds that the majority of respondents considered the LGU's preparedness and awareness in terms of knowledge, preparedness, information update, and preventive measures to be highly effective.
3. The study recommends extending community quarantines, increasing testing and resources for frontline healthcare workers, continuing economic relief for those impacted, and increasing investment in research institutions.
The document outlines South Africa's strategy for rolling out Covid-19 vaccines. It establishes a Ministerial Advisory Committee on vaccines to provide advice on vaccine options, purchasing, priority groups, and rollout strategy. It proposes a phased rollout approach prioritizing healthcare workers, essential workers, elderly, and those with comorbidities. The strategy considers vaccine selection criteria like availability, efficacy, storage requirements, and cost. It also addresses regulatory approvals, procurement, distribution, data collection, and negotiations with vaccine manufacturers.
“CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting”PYA, P.C.
PYA Principal Martie Ross spoke at the virtual North Carolina Healthcare Association Critical Access Hospital Statewide Meeting. The two-day event, “Quality Focus is a Finance Focus,” provided critical access hospital leaders with the opportunity to network and review data-informed strategies as well as updates to the Medicare Flexibility Program Project. It also provided guidance on federal compliance and tracking of Provider Relief Funds.
In “CARES Act Provider Relief Fund: Opportunities, Compliance, and Reporting,” Martie gave an overview of the history of distribution of those funds as well as regulations and guidelines including:
Statutory Language
Reporting Requirements
Use of Funds Calculation
Expenses
Risk Management
Martie presented Thursday, March 4, 2021.
If you would like guidance related to Provider Relief Fund regulations, or for assistance with any matter related to strategy and integration, compliance, or valuation, contact one of our PYA executives at (800) 270-9629.
The Fight Against COVID-19: A National Patient RegistryHealth Catalyst
Comprehensive COVID-19 understanding is a critical asset for adapting to pandemic needs, directing resources, developing vaccines, and planning for surges in a timely, informed manner. Because common barriers have impeded the progress of comprehensive data repositories, researchers have relied on surveillance data from population-level viral testing, which has proven insufficient. To significantly advance COVID-19 understanding, the medical community needs a digital patient registry that captures national-level data on how the virus impacts individuals differently according to comorbidities, lifestyle factors, and more. These essential insights lie in real-world evidence, which a registry can only deliver when it applies value sets to leverage clinical and claims data from health systems across the United States.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of December 2021. However, concerns are raised about the capacity to produce enough doses to vaccinate those aged 18-44 by that time.
2) The previous single procurement model, where the central government procured vaccines for all, has been replaced with a liberalized policy where states must procure vaccines for those 18-44 from private manufacturers.
3) Differential pricing has been introduced, with states paying more per dose than the central government's rate. This is argued to disproportionately impact certain states and individuals.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
The document discusses India's COVID-19 vaccination policy and the Supreme Court's consideration of related issues. It notes that:
1) The vaccination drive is scheduled to be complete by the end of 2021, with the central government in talks to procure more vaccines.
2) Concerns were raised about the "Liberalized Vaccination Policy" including differential pricing, the burden placed on states, and inadequate vaccine production to meet targets.
3) The Amici Curiae recommended reverting to a single procurement model led by the central government, as was followed for phases 1 and 2, to negotiate fair prices and equitably vaccinate the entire population.
Leaving no one behind: Progress on Life Course Immunisation Roundtable – alon...ILC- UK
Leaving no one behind: Progress on Life Course Immunisation Roundtable – alongside the World Health Assembly
Date: Tuesday 23 May 2023
Time: 13.00 – 14.30 (CET), followed by refreshments
Location: Geneva Press Club, Geneva, Switzerland
COVID Vaccine Lawsuit How to Battle your InjuryEdwina Johnson
It is crucial to discuss COVID vaccine injuries and COVID vaccine lawsuits. Medical innovations, particularly vaccine engineering, have a long road ahead of them, but it is one that is paved with a resolve to see to it that people get the treatment and pay they are legally entitled to.
The document summarizes Africa's joint continental strategy for responding to the COVID-19 pandemic, as endorsed by African Union health ministers in February 2020. It outlines the objectives of limiting virus transmission, severe illness, and social/economic disruption. It then describes Africa CDC's coordination of the response, including convening regular meetings, providing guidance and training to member states, deploying rapid response teams, and distributing medical supplies. It also discusses the Africa Medical Supplies Platform established to ensure member states can access critical supplies, and the AU COVID-19 Response Fund set up to address the pandemic's socioeconomic and humanitarian impacts.
When it comes to telehealth, in 2020 so many things changed and we continue to see changes into 2021. While some changes are designated as temporary; others such as the expansion of certain telehealth services may be here to stay. During this presentation, we’ll discuss the changes in telemedicine as a result of COVID-19; what was included in temporary Social Security Act section 1135 waivers and what telemedicine services are expected to remain after the public health emergency is officially over.
We’ll then move on to a more recent challenge with COVID-19 vaccines. We’ll review the vaccines approved for Emergency Use Authorization, and discuss billing guidelines from CMS.
Whether your organization is PPS, CAH, FQHC, RHC or IHS, during this information-packed webinar, we will be addressing vaccine billing guidance for all facility types.
Crossing the Rubicon: Post Covid-19 PolicyKan Yuenyong
The document discusses development policy strategies for post-COVID resilience and recovery. It notes that COVID has exposed weaknesses in economies and increased inequalities. Key issues for sustainable recovery include better health/well-being, cleaner air, public participation, equitable resilience, and pursuing a green/digital/inclusive transformation. Fiscal policy priorities are continuing support, implementing measures efficiently, and pursuing medium-term strategies. Global cooperation is needed on public health and stimulating growth.
This guidance from the WHO provides recommendations for countries to maintain essential health services during the COVID-19 outbreak. It suggests establishing simplified governance mechanisms to coordinate the response while continuing essential services. Countries should identify which services are most critical to prioritize, and may need to optimize service delivery locations and platforms. It also emphasizes the importance of effective patient screening, triage, and referral processes. Finally, the document recommends rapidly redistributing health workers through task sharing and reassignment to help address shortages caused by the increased demands of the outbreak.
Enforcement Discretion for Telehealth Remote Communications during COVID-19VSee
The Office for Civil Rights (OCR) at the Department of Health and Human Services announced it will not impose penalties on healthcare providers for HIPAA non-compliance related to good faith provision of telehealth during the COVID-19 pandemic. OCR will allow popular video communication technologies like FaceTime, Facebook Messenger video, and Google Hangouts for telehealth without penalties. However, public-facing apps like Facebook Live should not be used. OCR encourages use of encrypted, HIPAA-compliant options and notifies that it has not reviewed specific vendors' agreements.
सुप्रीम कोर्ट ने यह भी माना था कि मजिस्ट्रेट का यह कर्तव्य है कि वह सुनिश्चित करे कि अधिकारी पीएमएलए के तहत निर्धारित प्रक्रिया के साथ-साथ संवैधानिक सुरक्षा उपायों का भी उचित रूप से पालन करें।
Genocide in International Criminal Law.pptxMasoudZamani13
Excited to share insights from my recent presentation on genocide! 💡 In light of ongoing debates, it's crucial to delve into the nuances of this grave crime.
Lifting the Corporate Veil. Power Point Presentationseri bangash
"Lifting the Corporate Veil" is a legal concept that refers to the judicial act of disregarding the separate legal personality of a corporation or limited liability company (LLC). Normally, a corporation is considered a legal entity separate from its shareholders or members, meaning that the personal assets of shareholders or members are protected from the liabilities of the corporation. However, there are certain situations where courts may decide to "pierce" or "lift" the corporate veil, holding shareholders or members personally liable for the debts or actions of the corporation.
Here are some common scenarios in which courts might lift the corporate veil:
Fraud or Illegality: If shareholders or members use the corporate structure to perpetrate fraud, evade legal obligations, or engage in illegal activities, courts may disregard the corporate entity and hold those individuals personally liable.
Undercapitalization: If a corporation is formed with insufficient capital to conduct its intended business and meet its foreseeable liabilities, and this lack of capitalization results in harm to creditors or other parties, courts may lift the corporate veil to hold shareholders or members liable.
Failure to Observe Corporate Formalities: Corporations and LLCs are required to observe certain formalities, such as holding regular meetings, maintaining separate financial records, and avoiding commingling of personal and corporate assets. If these formalities are not observed and the corporate structure is used as a mere façade, courts may disregard the corporate entity.
Alter Ego: If there is such a unity of interest and ownership between the corporation and its shareholders or members that the separate personalities of the corporation and the individuals no longer exist, courts may treat the corporation as the alter ego of its owners and hold them personally liable.
Group Enterprises: In some cases, where multiple corporations are closely related or form part of a single economic unit, courts may pierce the corporate veil to achieve equity, particularly if one corporation's actions harm creditors or other stakeholders and the corporate structure is being used to shield culpable parties from liability.
Sangyun Lee, 'Why Korea's Merger Control Occasionally Fails: A Public Choice ...Sangyun Lee
Presentation slides for a session held on June 4, 2024, at Kyoto University. This presentation is based on the presenter’s recent paper, coauthored with Hwang Lee, Professor, Korea University, with the same title, published in the Journal of Business Administration & Law, Volume 34, No. 2 (April 2024). The paper, written in Korean, is available at <https://shorturl.at/GCWcI>.
This document briefly explains the June compliance calendar 2024 with income tax returns, PF, ESI, and important due dates, forms to be filled out, periods, and who should file them?.
Defending Weapons Offence Charges: Role of Mississauga Criminal Defence LawyersHarpreetSaini48
Discover how Mississauga criminal defence lawyers defend clients facing weapon offence charges with expert legal guidance and courtroom representation.
To know more visit: https://www.saini-law.com/
Business law for the students of undergraduate level. The presentation contains the summary of all the chapters under the syllabus of State University, Contract Act, Sale of Goods Act, Negotiable Instrument Act, Partnership Act, Limited Liability Act, Consumer Protection Act.
The Future of Criminal Defense Lawyer in India.pdfveteranlegal
https://veteranlegal.in/defense-lawyer-in-india/ | Criminal defense Lawyer in India has always been a vital aspect of the country's legal system. As defenders of justice, criminal Defense Lawyer play a critical role in ensuring that individuals accused of crimes receive a fair trial and that their constitutional rights are protected. As India evolves socially, economically, and technologically, the role and future of criminal Defense Lawyer are also undergoing significant changes. This comprehensive blog explores the current landscape, challenges, technological advancements, and prospects for criminal Defense Lawyer in India.
What are the common challenges faced by women lawyers working in the legal pr...lawyersonia
The legal profession, which has historically been male-dominated, has experienced a significant increase in the number of women entering the field over the past few decades. Despite this progress, women lawyers continue to encounter various challenges as they strive for top positions.
Receivership and liquidation Accounts
Being a Paper Presented at Business Recovery and Insolvency Practitioners Association of Nigeria (BRIPAN) on Friday, August 18, 2023.
From Promise to Practice. Implementing AI in Legal Environments
LEG MED RA 11525.pptx
1. Dr. Al-Fairylyn V. Bagcat , MD, JD
Professsor- Legal Medicine
REPUBLIC ACT NO. 11525
February 26, 2021
AN ACT ESTABLISHING THE CORONAVIRUS DISEASE 2019 (COVID-19) VACCINATION PROGRAM EXPEDITING THE
VACCINE PROCUREMENT AND ADMINISTRATION PROCESS, PROVIDING FUNDS THEREFOR, AND FOR OTHER
PURPOSES
LEGAL MEDICINE
Misamis University
College of Law
PACULANANG, FRANCES DAVE L.
PAGUYA, EZA E.
PONCE, MIERRA FLOR V
JD4-B
2. Section 1. Short Title
• This Act shall be known and
cited as the "COVID-19
Vaccination Program Act of
2021".
3. Section 2. Declaration of Policy
• (a) Address the adverse impact of COVID-19 through the procurement and administration of safe
and effective COVID-19 vaccines by the National Government through the Department of Health
(DOH) and the National Task Force Against COVID-19 (NTF) and other duly constituted authorities
and instrumentalities;
• (b) Source and procure through the DOH and the NTF, either through themselves jointly or in
cooperation with any national govenrment agency or instrumentality or local government unit
(LGU), safe and effective COVID-19 vaccines;
• (c) Recognize the experimental nature of COVID-19 vaccines available in the market and
compensate any serious adverse effects (SAEs) arising from the use of COVID-19 vaccine,
experienced by people inoculated through the COVID-19 Vaccination Program; and
• (d) Creation of a COVID-19 National Vaccine Indemnity Fund to be administered by the Philippine
Health Insurance Corporation (PhilHealth) to compensate persons encountering SAE pursuant to
the preceding paragraph.
4. Section 3. Procurement of COVID-19 Vaccines and
Ancillary Supplies and Services.
• DOH and the NTF, either through
themselves jointly or in cooperation with
any national government agency or
instrumentality or LGU, are authorized to
procure COVID-19 vaccines, including
ancillary supplies and services necessary
for their storage, transport, deployment,
and administration
5. Section 4. Procurement and Administration of
COVID-19 Vaccines and Ancillary Supplies and
Services by Local Government Units.
• Provinces, cities and municipalities may procure only in cooperation with the DOH and the NTF through a
multiparty agreement
• Provided That these LGUs shall procure no more than seventy-five percent (75%) of their target population for
vaccination
• Provided That the seventy-five percent (75%) cap may be adjusted by the Iner-Agency Task Force for the
Management of Emerging Infectious Diseases (IATF-EID) when there is sufficient supply of vaccines as determined
by DOH and the NTF
• Provided That LGUs may directly accept donations of FDA-authorized and cleared COVID-19 vaccines, subject to
the guidelines and reportorial requirements of the DOH and the NTF
• Provided, finally, That this section shall have retroactive application from January 1, 2021.
• To ensure transparency, the LGUs shall also submit to the DOH a masterlist of the names and profiles of the
residents who were vaccinated under the COVID-19 Vaccination Program, subject to the provisions of the Data
Privacy Act.
6. Section 5. Procurement and Administration of
COVID-19 Vaccines by Private Entities.
• Private entities may procure
COVID-19 vaccines only in
cooperation with the DOH and
the NTF.
7. Section 6. Transparency and Accountability in
COVID-19 Vaccine Procurement.
• COVID-19 vaccines
that are registered
with the Philippine
Food and Drug
Administration (FDA)
8. Section 7. Authority to Make Recommendations
Based on Preliminary Data from Phase III Clinical
Trails.
• The Health Technology
Assessment Council (HTAC)
shall have the authority to
make recommendations to
the DOH on COVID-19
vaccines
9. Section 8. Immunity from Liability
• Public officials and employees,
contractors, manufacturers,
volunteers, and representatives
of duly authorized private entities
who are duly authorized to carry
out and are actually carrying out
the COVID-19 Vaccination
Program shall be immune from
suit and liability
10. Section 9. Pharmacists and Midwives as
Vaccinators.
• Licensed pharmacists and
midwives who are duly
trained by the DOH may
administer COVID-19 vaccines
11. Section 10. COVID-19 National Vaccine
Indemnity Fund.
• The COVID-19 National
Vaccine Indemnity Fund,
which shall be administered
by PhilHealth
• in case of death, permanent disability
or hospital confinement
12. Section 11. Exemption from Import Duties, Taxes and Other Fees
for the Procurement, Deployment and Administration of COVID-
19 Vaccines.
• COVID-19 Vaccination Program
by the government or any of
its political subdivisions and by
private entities shall be exempt
from customs duties, value-
added tax, excise tax, donor's
tax, and other fees
13. Section 12. COVID-19 Vaccine Card.
• DOH shall issue a vaccine
card to all persons
vaccinated subject to the
provisions of Republic Act
No. 10173 or the "Data
Privacy Act of 2012"
14. Section 13. Reportorial Requirement and
Creation of an Oversight Committee
• Upon the effectivity of
this Act, the Vaccine Czar,
the DOH and the IATF-EID
shall submit a monthly
report to Congress on the
implementation of the
COVID-19 Vaccination
Program
15. Section 14. Implementing Rules and
Regulations.
• Issuance of guidelines and
applicable procurements
rules within 5 days from the
effectivity of this act.
16. Current News
Maria Rosario Vergeire
Department of Health Officer-in-Charge
• The Department of Health
(DOH) is recommending the
amendment of Republic Act
(RA) 11525 as of August 16,
2022
• The DOH said this is in case
the state of calamity
declaration due to the
coronavirus disease 2019
(Covid-19) is not extended.
Notwithstanding any law to the contrary, the DOH and the NTF, either through themselves jointly or in cooperation with any national government agency or instrumentality or LGU, are authorized to procure COVID-19 vaccines, including ancillary supplies and services necessary for their storage, transport, deployment, and administration through Negotiated Procurement under Emergency Cases pursuant to Section 53(b) of Republic Act No. 9184 and Section 53.2 of the 2016 Revised Implementing Rules and Regulations of Republic Act No. 9184:
If the procurement of vaccine is funded by the National Government, the LGU shall comply with the science and evidence-based terms and conditions of deployment, prioritizing the needs of the following groups: healthcare workers; senior citizens; persons with comorbidities; frontline personnel in essential services, including uniformed personnel and teachers; and indigent population: Provided, That an LGU is authorized to directly procure ancillary supplies and services necessary for the storage, transport, deployment and administration of COVID-19 vaccines through negotiated procurement under emergency cases prescribed under this section.
For LGU-funded vaccines, the inoculation order must, at all times, be science and evidence-based, prioritizing the needs of the following special groups: frontline workers in health facilities, senior citizens, and indigent persons: Provided, That the local health officials shall be allowed to formulate their own vaccine recipient list and implement their own operational procedures in accordance with the national policies and procedures issued by the DOH if it will expedite and enhance the efficiency of the inoculation process and prevent the spoilage of vaccines
Private entities may procure COVID-19 vaccines only in cooperation with the DOH and the NTF through a multiparty agreement, which shall include the DOH and the relevant supplier of COVID-19 vaccine
Any such vaccines, supplies or services procured by private entities shall be for the sole and exclusive use of such companies, without prejudice to the multiparty agreement: Provided, That priority in the inoculation shall be given to its healthcare workers, senior citizens, economic frontliners, and essential workers: Provided, further, That the chief medical officers of private entities shall be allowed to formulate their own vaccine recipient list and implement their own operational procedures in accordance with the national policies and procedures issued by the DOH if it will expedite and enhance the efficiency of the inoculation process and prevent the spoilage of vaccines: Provided, finally, That this section shall have retroactive application from November 1, 2020.
With respect to international humanitarian organizations, such as the Red Cross movement, particularly the Philippine Red Cross, a voluntary, independent and autonomous nongovernmental society auxiliary to the authorities of the Republic of the Philippines in the humanitarian field, as set forth in Republic Act No. 11072, known as the "Philippine Red Cross Act of 2009", may procure COVID-19 vaccines: Provided, That the vaccines procured shall be for the use of individuals consistent with the priority list set, wherein for every one vaccine bought one vaccine shall be donated to the vulnerable and indigent.
The DOH, NTF, LGUs and private entities procuring COVID-19 vaccines may partner with the Philippine Red Cross in the administration or distribution and inoculation of the vaccines.
The National Government, as well as LGUs, private entities and the Philippine Red Cross, may only procure COVID-19 vaccines that are registered with the Philippine Food and Drug Administration (FDA) as evidenced by a valid Certificate of Product Registration or which possess an Emergency Use Authorization (EUA).
For purposes of transparency, the following information shall be posted in a conspicuous place of the Procuring Entity and in the Government Procurement Policy Board (GPPB) Online Portal within thirty (30) days after award or execution of definitive agreement or after the effectivity of this Act, whichever is applicable:
(a) Approved budget for the contract;
(b) Name and details of the COVID-19 vaccine or ancillary service or supplies;
(c) Name of the supplier, manufacturer, or distributor; and
(d) Amount of contract as awarded.
The Health Technology Assessment Council (HTAC) shall have the authority to make recommendations to the DOH on COVID-19 vaccines based on preliminary data from Phase III clinical trials and World Health Organization recommendations, in the absence of completed Phase III and Phase IV clinical trials
Provided, That the COVID-19 vaccine manufacturer has been issued an EUA by the FDA: Provided further, That the authority granted to the HTAC herein shall only be valid for as long as the EUA issued by the FDA is in effect, such that in the event of revocation or cancellation thereof by the FDA Director General, the HTA process shall be terminated regardless of stage, and if it has been completed, the results shall be set aside.
Notwithstanding any law to the contrary, public officials and employees, contractors, manufacturers, volunteers, and representatives of duly authorized private entities who are duly authorized to carry out and are actually carrying out the COVID-19 Vaccination Program shall be immune from suit and liability under Philippine laws with respect to all claims arising out of, related to, or resulting from the administration or use of a COVID-19 vaccine under the COVID-19 Vaccination Program except arising from willful misconduct and gross negligence
Notwithstanding the provisions of Section 4(g) of Republic Act No. 10918, otherwise known as the "Philippine Pharmacy Act", and Section 23 of Republic Act No. 7392, otherwise known as the "Philippine Midwifery Act of 1992", and in furtherance of the COVID-19 Vaccination Program, licensed pharmacists and midwives who are duly trained by the DOH may administer COVID-19 vaccines that are registered with the FDA or which possess an EUA.
is hereby established as a trust fund to compensate any person inoculated through the COVID-19 Vaccination Program, in case of death, permanent disability or hospital confinement for any SAEs: Provided, That in case of death and permanent disability, PhilHealth is hereby authorized to pay compensation from the indemnity fund.
The amount of Five hundred million pesos (P500,000,000.00) is hereby authorized to augment the funds of PhilHealth for this purpose which shall be sourced from the Contingent Fund, as provided under Republic Act No. 11518 or the General Appropriations Act of 2021.
The indemnity fund shall be valid and available for release and disbursement until terminated by thePresident of the Philippines, based on the recommendation of the Permanent Committee, which was created under Executive Order No. 292, s. 1987, that the purpose for which it has been established has been fulfilled. The Permanent Committee shall also determine the amount that shall revert to the National Treasury upon its termination. The PhilHealth, in consultation with the DOH, the Department of Finance, the Department of Budget and Management and the NTF, shall issue the necessary guidelines for the planning, administration, and monitoring of the utilization of the fund, including the determination of its sufficiency.
For this purpose, the IATF-EID shall establish a Special Task Group composed of medical and vaccine experts with proven track record who will be in charge of monitoring the probable adverse effects following immunization from COVID-19. The Special Task Group shall promulgate the necessary guidelines on the monitoring, evaluation, investigation and reporting mechanism to be followed by all LGUs: Provided, That this section shall be vaid and in effect for a period of five (5) years from the effectivity of this Act or until the government has declared the completion of the COVID-19 Vaccination Program, whichever comes earlier.
Beginning January 1, 2021, the procurement, importation, donation, storage, transport, deployment, and administration of COVID-19 vaccines through the COVID-19 Vaccination Program by the government or any of its political subdivisions and by private entities shall be exempt from customs duties, value-added tax, excise tax, donor's tax, and other fees
Provided, That the vaccines shall not be intended for resale or other commercial use and shall be distributed without consideration from persons to be vaccinated.
The issuance of a vaccine card is intended to be digital, but shall remain accessible through other means such as printed cards.
Individuals vaccinated against COVID-19 as indicated in the vaccine card shall not be considered immune from COVID-19, unless otherwise declared by the DOH based on reliable scientific evidence and consensus.
No fees shall be collected for the issuance, amendment, or replacement of a vaccine card. The amount needed for the initial implementation shall be charged against available funds for the purpose. Thereafter, such sums as may be necessary for its continued implementation shall be included in the annual General
Appropriations Act.
The falsification of a vaccine card shall be punishable under Act No. 3185, as amended, otherwise known as "The Revised Penal Code".
or this purpose, Congress shall establish a Joint Congressional Oversight Committee composed of four (4) Members of each House to be appointed by the Senate President and the House Speaker, respectively. The Committee shall determine whether the implementation of the COVID-19 Vaccination Program conforms with the provisions of this Act.
Within five (5) days from the effectivity of this Act, the DOH, the NTF and the GPPB shall, with prior consultation with the Department of the Interior and Local Government, the IATF-EID and other stakeholders, issue guidelines and applicable procurement rules, as may be necessary, for the effective implementation of this Act.
The non-promulgation of the rules and regulations provided under this section shall not prevent the immediate implementation of this Act upon its effectivity.
Former President Rodrigo Duterte extended the state of calamity throughout the country for one year from Sept. 13, 2021 to Sept. 12, 2022 under Proclamation 1218.
Apart from the national vaccination drive, Vergeire noted there are other protocols which are linked with the declaration of state of calamity due to Covid-19.
These are emergency use authority (EUA) for Covid-19 jabs, emergency procurement of vaccines, tax exemptions for vaccine manufacturers and donors, price caps on medicines used for Covid-19 treatment, and additional benefits of healthcare workers.
“Nakikipag-usap tayo sa (We’re discussing with the) legislative branch of government for us to amend RA 11525,” she said.
“EUA for vaccines still needs to continue, until now only one manufacturer has submitted [application for certificate of product registration],” she added.
As of August 15, more than 72.1 million Filipinos have been fully vaccinated.
More than 17 million individuals have received their first booster dose while more than 1.8 million got their second booster shot. (PNA)